Filing Details

Accession Number:
0001127602-15-009677
Form Type:
4
Zero Holdings:
No
Publication Time:
2015-03-03 17:34:48
Reporting Period:
2015-03-02
Filing Date:
2015-03-03
Accepted Time:
2015-03-03 17:34:48
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1520262 Alkermes Plc. ALKS Pharmaceutical Preparations (2834) 981007018
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1236441 A Robert Breyer Connaught House
1 Burlington Road
Dublin 4 Ireland
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Ordinary Shares Acquisiton 2015-03-02 5,000 $14.92 58,156 No 4 M Direct
Ordinary Shares Disposition 2015-03-02 5,000 $70.86 53,156 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Ordinary Shares Non Qualified Stock Option (Right to Buy) Disposition 2015-03-02 5,000 $0.00 5,000 $14.92
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
5,000 2020-10-05 No 4 M Direct
Footnotes
  1. This option exercise was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
  2. The sale was effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person.
  3. These options are fully vested in accordance with their terms.